Position in ANRO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,255,817
+$315,007 QoQ
Shares Held
85,480
-1.0% QoQ
Ownership
0.218%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 114 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in ANRO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $538,947,950 across 105 Biotechnology names. ANRO ranks #32 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHVN |
Biohaven Ltd.
|
9,941,165 | $147,924,534 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
162,151 | $80,545,262 | |
| 3 | MANE |
Veradermics, Inc
|
294,117 | $36,158,743 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
139,491 | $33,613,146 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
46,378 | $28,918,535 | |
| 6 | OMER |
Omeros Corp
|
1,836,925 | $17,469,155 | |
| 7 | NTLA |
Intellia Therapeutics, Inc.
|
1,014,387 | $17,163,427 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
202,983 | $16,094,521 |
All Filings in ANRO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,255,817 | 85,480 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,940,810 | 86,335 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,551,519 | 87,164 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $490,440 | 122,000 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $279,076 | 126,853 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $281,104 | 130,141 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $544,401 | 128,700 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||